Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 30: 399-403, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jongen, M. J.
Right arrow Articles by Lips, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jongen, M. J.
Right arrow Articles by Lips, P.

Clinical Chemistry, Vol 30, 399-403, Copyright © 1984 by American Association for Clinical Chemistry

An international comparison of vitamin D metabolite measurements

MJ Jongen, FC Van Ginkel, WJ van der Vijgh, S Kuiper, JC Netelenbos and P Lips

An international 19-laboratory survey was organized to compare assays for 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25- dihydroxyvitamin D in plasma. Each participant received two ethanolic standard solutions of each metabolite and eight plasma samples. Each laboratory used its usual procedures. Mean interlaboratory coefficients of variation (CVs) for the eight plasma samples were 35%, 43%, and 52% for 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25- dihydroxyvitamin D, respectively. Average CVs for the standard solutions were 27%, 23%, and 25%, respectively. Of the eight plasma samples, five had the same concentration for one of the metabolites. One sample was diluted to 0.6 times its original concentration and three samples were fortified with one or more of the metabolites under investigation. Fourteen of 18 laboratories (78%) could distinguish between the five unchanged samples and the modified ones with their 25- hydroxyvitamin D assay. Nine of 12 (75%) could distinguish the modified samples from the other samples with the 24,25-dihydroxyvitamin D assay. Only eight of 15 (53%) could do this their 1,25-dihydroxyvitamin D assay. Values from different laboratories evidently cannot be intercompared without making an actual comparison of the assay procedures. Furthermore, in case of clinical applications of these assays, each laboratory should establish its own reference values and should continually use an internal reference sample to assess the precision of the procedures.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
I. Seiden-Long and R. Vieth
Evaluation of a 1,25-Dihydroxyvitamin D Enzyme Immunoassay
Clin. Chem., June 1, 2007; 53(6): 1104 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Animal Hospital AssociationHome page
P. de Fornel-Thibaud, G. Blanchard, L. Escoffier-Chateau, S. Segond, F. Guetta, D. Begon, F. Delisle, and D. Rosenberg
Unusual Case of Osteopenia Associated With Nutritional Calcium and Vitamin D Deficiency in an Adult Dog
J. Am. Anim. Hosp. Assoc., January 1, 2007; 43(1): 52 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Binkley, D. Krueger, C. S. Cowgill, L. Plum, E. Lake, K. E. Hansen, H. F. DeLuca, and M. K. Drezner
Assay Variation Confounds the Diagnosis of Hypovitaminosis D: A Call for Standardization
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3152 - 3157.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Valmadrid, C. Voorhees, B. Litt, and C. R. Schneyer
Practice Patterns of Neurologists Regarding Bone and Mineral Effects of Antiepileptic Drug Therapy
Arch Neurol, September 1, 2001; 58(9): 1369 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Lips
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
Endocr. Rev., August 1, 2001; 22(4): 477 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Vieth
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
Am. J. Clinical Nutrition, May 1, 1999; 69(5): 842 - 856.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. S. LeBoff, L. Kohlmeier, S. Hurwitz, J. Franklin, J. Wright, and J. Glowacki
Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Fracture
JAMA, April 28, 1999; 281(16): 1505 - 1511.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Lind, J. Chen, and I. Byrjalsen
Enzyme immunoassay for measuring 25-hydroxyvitamin D3 in serum
Clin. Chem., June 1, 1997; 43(6): 943 - 949.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.